Research map: Ultrasensitive circulating tumor DNA detection improves prognostication in triple-negative breast cancer postneoadjuvant therapy

Back to the article

Papers in this map

  1. SciPy 1.0: fundamental algorithms for scientific computing in Python · Pauli Virtanen · 2020 · 40235 citations · Cited by this paper
  2. Axillary De-Escalation After Neoadjuvant Therapy in cN2/N3 HER2-Positive and Triple-Negative Breast Cancer: Navigating Biological Promise and Clinical Uncertainty · Kefah Mokbel · 2026 · Cites this paper
  3. 61eP Radiotherapy combined with PARP inhibition in BRCA-mutated breast cancer: A systematic review of clinical outcomes and toxicity · 2026 · Related
  4. Array programming with NumPy · Charles R. Harris · 2020 · 23983 citations · Cited by this paper
  5. Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targets · 2026 · Related
  6. Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer · Jeanne Tie · 2022 · 1082 citations · Cited by this paper
  7. 149P Adjuvant radiotherapy outcomes for early stage (stage 1c-2) clear cell ovarian carcinoma in Edinburgh cancer centre · 2026 · Related
  8. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients · Christina Yau · 2021 · 467 citations · Cited by this paper
  9. 213P Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: A dosimetric comparison · 2026 · Related
  10. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA · David Matthew Kurtz · 2021 · 389 citations · Cited by this paper
  11. 194eP Ovarian cancer during pregnancy: Maternal and fetal outcomes from a systematic review and meta-analysis · 2026 · Related
  12. scikit-posthocs: Pairwise multiple comparison tests in Python · Maxim A. Terpilowski · 2019 · 376 citations · Cited by this paper
  13. 67RO Single-cell and TCR profiling reveals pre-existing cytotoxic CD8 T cell clonal expansion and peripheral–tumor dissociation associated with response to PD-1-based therapy in hepatocellular carcinoma · 2026 · Related
  14. Jupyter: Thinking and Storytelling With Code and Data · Brian Granger · 2021 · 266 citations · Cited by this paper
  15. 219P Clinical profile and treatment outcomes of lymphoma patients: A retrospective cohort study · 2026 · Related
  16. Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0 · Sara M. Tolaney · 2021 · 236 citations · Cited by this paper
  17. A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma) · 2026 · Related
  18. Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer · Francesca Riva · 2017 · 220 citations · Cited by this paper
  19. 152P Efficacy and safety of relacorilant + nab-paclitaxel in patients aged ≥65 years with platinum-resistant ovarian cancer (PROC) in the phase III ROSELLA study (GOG-3073, ENGOT-ov72, APGOT-Ov10) · 2026 · Related
  20. Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy · Mark Jesus M. Magbanua · 2023 · 194 citations · Cited by this paper
  21. 232eP GLP-1 receptor agonists and risk of incident endometrial, colorectal, and hepatocellular cancer: A systematic review and meta-analysis · 2026 · Related
  22. Use of ctDNA in early breast cancer: analytical validity and clinical potential · François Panet · 2024 · 112 citations · Cited by this paper
  23. Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma · James R. Black · 2025 · 106 citations · Cited by this paper
  24. Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030 · Heather Anne Parsons · 2023 · 69 citations · Cited by this paper
  25. Whole genome sequencing-powered ctDNA sequencing for breast cancer detection · Isaac García-Murillas · 2025 · 58 citations · Cited by this paper
  26. TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy · Aditya Bardia · 2024 · 49 citations · Cited by this paper
  27. Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay · Josette M. Northcott · 2024 · 38 citations · Cited by this paper
  28. Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer · Mitchell J. Elliott · 2025 · 37 citations · Cited by this paper
  29. Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assay · Mitchell J. Elliott · 2025 · 35 citations · Cited by this paper
  30. Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA · Jennifer Hechao Chen · 2024 · 31 citations · Cited by this paper
  31. Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis · Diana Zhang · 2025 · 24 citations · Cited by this paper
  32. ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis · Mikail Gögenur · 2022 · 17 citations · Cited by this paper
  33. Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α‐CORRECT Study · Brenda B. Diergaarde · 2025 · 13 citations · Cited by this paper
  34. Clinical performance of Signatera Genome assay in a cohort of patients (pts) with solid tumors. · Mridula Annette George · 2025 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)